Our previous research has demonstrated that inhibiting the transcriptional activity of CREB, a crucial downstream transcription factor of cAMP, effectively delays the progression of ADPKD by suppressing the expression of cyst-promoting genes (Liu et al, 2021). The gene discussed is CREB1; the disease is autosomal dominant polycystic kidney disease.